BIONNALE 2016

AGENDA

 Download the printer-friendly agenda here.

CONFERENCE PROGRAMME

Agenda 2016

 

Detailed Agenda

Biotech | Pharma - Agenda I

Diagnostics for Drug Targeted Therapies – Perspectives, Challenges & Projects
Biotech meets Pharma

13:30 - 13:35
Welcome / Chair
Dr. Sabine Sydow, Head of vfa bio
Dr. Christine Mißler, Berlin Partner for Business and Technology

13:35 - 13:50
Introduction
Dr. Thorsten Ruppert
Senior Manager, Research Development Innovation, vfa

13:55 - 14:10
Do pharma companies with own diagnostic expertise need external partners for their drug-diagnostic development? 
Dr. Sanne de Haas
Scientific Manager Oncology Biomarker Development, Roche/Genentech

14:15 - 14:30
How do pharma companies without own diagnostic business manage drug targeted therapies?
Dr. Daniel Forler
Alliance Management; Global External Innovation & Alliances, Bayer Pharma

14:35 - 14:50
From biomarker finding to CDx product: How to proceed?
Dr. Jörg-M. Hollidt
Chairman of the Executive Board, DiagnostikNet-BB

15:00 - 15:30
Coffee Break

 

Biotech | Pharma - Agenda II

Diagnostics for Drug Targeted Therapies – Perspectives, Challenges & Projects
Biotech meets Pharma

15:30 - 15:45
Individualized diagnostics for a personalized therapy
Prof. Dirk Roggenbuck
CEO, Medipan GmbH, Spokesman, PARMENIDes consortium

15:50 - 16:05
Metabolic biomarker based screening enabling potential curative treatment of pancreatic cancer
Dr. Philipp Schatz
Head of Biomarker Program, Metanomics Health GmbH

16:10 - 16:25
Nuclear medicine theragnostics: A new approach for the treatment of pancreatic carcinoma
Dr. Ulrich Reineke
CEO, 3B Pharmaceuticals GmbH

16:30 - 16:40
Closing remarks
Dr. Kai Schulze-Forster
Spokesman, Companion Diagnostics Network

 

Medical Technology - Agenda I

Orthopedic Medical Technology

13:30 - 13:40
Welcome / Chair
Dr. Helmut Kunze / Steffen Mackschin
Berlin Partner for Business and Technology, Berlin

13:40 - 14:00
Bio-inspired Engineering – new concepts for bone regeneration
Univ. Prof. Dr.-Ing. Georg N. Duda
Director, Julius Wolff Institute & Deputy Director, Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin Berlin

14:00 - 14:20
Infection in Orthopedics - Addressing the Clinical Challenge
Dr. Regis Cartier
Team Leader Research and Development, Zimmer Biomet Germany, Berlin

14:20 - 14:40
Biomaterials - routes toward addressing unmet needs
Dr. Joachim Storsberg
Head of Department Functional Polymers for Medical Technology, Fraunhofer Institute for Applied Polymer Research IAP, Potsdam

14:40 - 15:00
Inflammation in the Spot Light
Dr. Malte Bahner
CEO, mivenion GmbH, Berlin

15:00 - 15:30
Coffee break

 

Medical Technology - Agenda II

Cardiovascular Medical Technology

15:30 - 15:50
Current trends in cardiac valve replacement
Dr. Jörg Kempfert
Senior physician, German Heart Institute, Berlin

15:50 - 16:10
Bioresorbable Vascular Scaffolds – the innovation in coronary interventions
Dr. Nick West
Consultant Cardiologist, Abbott Vascular, UK

16:10 - 16:30
Principles of Biologisation in Ventricular Assist Devices and Regulatory Challenges
Hendrik Heinze
Director Quality & Regulatory Affairs, Berlin Heart GmbH, Berlin

16:30 - 16:50
Innovation in endoscopic vessel harvesting for coronary artery bypass graft surgery
Stefan Kürbis
Vice President Global Marketing, World of Medicine GmbH, Berlin

 

Biobased Industries #1

Impact of biobased technology on health industry

13:30 - 13:40
Welcome / Chair
Dr. Joachim Venus
Coordinator of the research program "Material and energetic use of biomass", Leibniz Institute for Agricultural Engineering Potsdam-Bornim e.V., Potsdam

13:40 - 14:00
Natural diversity of microbes – a unique resource for new product developments
Dr. Klaus Pellengahr
Director Business Development, Organobalance GmbH, Berlin

14:00 - 14:20
Turning industrial waste streams (CO2, glycerol) into valuable products: biobased perspective of food, cosmetics and chemical industry
Dr. Martin Langer
Executive Vice President Unit Head Corporate Development, BRAIN AG, Zwingenberg

14:20 - 14:40
Enzyme engineering as key technology for the commercialization of human milk oligosaccharides as novel food ingredients
Dr. Marc Struhalla
CEO, c-LEcta GmbH, Hamburg

14:40 - 15:00
Nanotechnology and material science for interdisciplinary medical innovation
Dr. Sam Dylan Moré
CEO, DendroPharm GmbH, Berlin

15:00 - 15:30
Coffee break

 

Biobased Industries #2

Impact of biobased technology on cross innovation

15:30 - 16:00
From third generation lignocellulose to the bioplastic
Dr. Peter Schroeder
CEO, Green Sugar GmbH, Meißen and Platon Solutions GmbH, Hamburg

16:00 - 16:30
Cascade utilisation of renewable materials
Elke Breitmayer,
Life Cycle Assessments, Economics & Resources, nova-Institut GmbH

16:30 - 16:50
Sustainable meets profitable: an innovative Landgut in Brandenburg
Michael Stober
CEO, Landgut Stober Kontor GmbH & Co. Betriebs KG, Nauen

 

Cooperation Track

Companies, universities and research institutions are invited to apply for a short presentation (10 minutes) on their competences. During the whole afternoon you can listen to short talks on various topics. From strategic partnerships, to process improvement, to co-development – talk about your expertise and share your needs when it comes to developing your research or product further. 

Track 1 - 13:30 -14:15 - Host: Volker Erb, Berlin Partner for Business and Technology
Digital Health Companion (Fraunhofer IGD-R) - mHealth-Dx Network -Fraunhofer IZI-BB - medipideo UG- ArztTechMarkt UG - Neurofox UG - labfolder GmbH - Chungbuk provincial office

Track 2 - 14.15-15.00 - Host: Dr. Philipp Rittershaus, High-Tech Gründerfonds Management GmbH
Bürkert GmbH & Co. KG - Network "PolyMed" Technical University Wildau - LLS ROWIAK LaserLabSolutions GmbH - HappyMed GmbH - Surflay Nanotec GmbH - BURL Concepts Inc.

Track 3 - 15.30-16.30 - Host: Benjamin Thiering, Berlin Partner for Business and Technology
oncgnostics GmbH – BIOTEM - BioTeZ GmbH - cpo Berlin-Buch GmbH - Fraunhofer IZI-BB – Texcell - XinTech (Bio Sciences) DE GmbH

Track 4 - 16.30-17.30 - Host: Dr. Boris Mannhardt, BIOCOM AG
St Gilesmedical - NMI TT Pharmaservices - MOLOGEN AG - BeaconCure - DexLeChem GmbH - Experimental Pharmacology & Oncology Berlin-Buch GmbH - Pure Biologics Sp. z o.o. (Ltd.) - Gilupi GmbH

 

Matchmaking Meetings

The organized matchmaking helps you to identify new contacts in the Berlin-Brandenburg region and beneath the international attendees of the Bionnale. You can search for potential partners via the web based matchmaking tool. Short meetings of 20 minutes are scheduled automatically to the participant’s convenience. It is possible to accept or decline requests from others. Your meeting schedule will be based on your accepted requests.

 

Speed Lecture Award

17:30 - 18:30

The three winners of the Speed Lecture Award are:

  1. Anja Schenk - Hochschule für Technik und Wirtschaft (HTW) Berlin, Fachbereich 2: Life Science Engineering
  2. Andreas Ofenbauer - Berlin Institute for Medical Systems Biology (BIMSB) at Max Delbrück Center (MDC)
  3. Thomas Seel - Technische Universität Berlin, Fachgebiet Regelungssysteme

Congratulations!

The list of finalists and more information is available here

 

Evening Reception and Networking

18:30 - 18:40
Welcome and short introduction
Interdisciplinary approaches in translational research
Prof. Dr. Andreas Lendlein
Director, Institute of Biomaterial Science, Helmholtz-Zentrum Geesthacht, Teltow
Vice-Director, Berlin Brandenburg Center for Regenerative Therapies (BCRT), Berlin

18:40 - 19:00
The Berlin Institute of Health – A novel ecosystem for innovation
Dr. Rolf Zettl
Administrative Director, Berlin Institute of Health (BIH), Berlin

19:00 - 19:20
Dealing with interdisciplinarity: the Barcelona Institute of Science and Technology model
Dr. Montserrat Vendrell
Director General, Barcelona Institute of Science and Technology (BIST), Barcelona/Spain

19:20 - 19:30
What are the needs of an industry player? – Reply from Bayer
Dr. Matthias Gottwald
Head R&D Policy & Networking, Bayer Pharma AG, Berlin

19:30 - 19:40
Closing Remarks
Dr. Kai Bindseil
Manager, Cluster HealthCapital, Berlin

19:40 - 19:50
Award Ceremony Speed Lecture Award
Dr. Sabine Sydow
Head of vfa bio, Berlin

Dr. Kai Bindseil
Manager, Cluster HealthCapital, Berlin

Moderation:
Dr. Melinda Crane

19:50 - 22:00
Get-together and Networking

 

 Download the printer-friendly agenda here.

Registration
closed since 24 May 2016
Organisers
Schedule
Registration 16 Jan – 24 May
Meeting Selection 25 Apr – 24 May
Event 25 May
Details
Language English
Costs Free of charge
Venue Berlin, Ludwig-Erhard-Haus
Bilateral Meetings
Participants 290
Meetings 333
Participants
Australia 1
Austria 4
Belarus 1
Belgium 4
Canada 2
Colombia 2
Czech Republic 1
Denmark 2
Estonia 2
Ethiopia 1
Finland 2
France 14
Germany 790
Ireland 1
Israel 1
Netherlands 5
Nigeria 1
Poland 9
Russian Federation 5
South Korea 2
Spain 4
Sweden 2
Switzerland 4
United Arab Emirates 1
United Kingdom 8
USA 10
Total 879
Profile Views
Before Event17497
After Event 7684
Total25181